HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A family with a hereditary form of torsion dystonia from northern Sweden treated with bilateral pallidal deep brain stimulation.

Abstract
To evaluate pallidal DBS in a non-DYT1 form of hereditary dystonia. We present the results of pallidal DBS in a family with non-DYT1 dystonia where DYT5 to 17 was excluded. The dystonia is following an autosomal dominant pattern. Ten members had definite dystonia and five had dystonia with minor symptoms. Four patients received bilateral pallidal DBS. Mean age was 47 years. The patients were evaluated before surgery, and "on" stimulation after a mean of 2.5 years (range 1-3) using the Burke-Fahn-Marsden scale (BFM). Mean BFM score decreased by 79 % on stimulation, from 42.5 +/- 24 to 9 +/- 6.5 at the last evaluation. Cervical involvement improved by 89%. The 2 patients with oromandibular dystonia and blepharospasm demonstrated a reduction of 95% regarding these symptoms. The present study confirms the effectiveness of pallidal DBS in a new family with hereditary primary segmental and generalized dystonia.
AuthorsPatric Blomstedt, Marwan I Hariz, Stephen Tisch, Monica Holmberg, Tommy A Bergenheim, Lars Forsgren
JournalMovement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 24 Issue 16 Pg. 2415-9 (Dec 15 2009) ISSN: 1531-8257 [Electronic] United States
PMID19890997 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright(c) 2009 Movement Disorder Society.
Chemical References
  • Molecular Chaperones
  • TOR1A protein, human
Topics
  • Adult
  • Deep Brain Stimulation (methods)
  • Dystonia Musculorum Deformans (genetics, therapy)
  • Family Health
  • Female
  • Globus Pallidus (physiology)
  • Humans
  • Male
  • Middle Aged
  • Molecular Chaperones (genetics)
  • Severity of Illness Index
  • Sweden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: